Directory
>
Melissa Junttila
Melissa Junttila
Vice President | ORIC Pharmaceuticals Inc.
San Mateo Highlands, California, United States
Melissa Junttila
Summary
Melissa Junttila is a distinguished Vice President and Head of Biology at ORIC Pharmaceuticals, where she spearheads innovative research aimed at tackling drug resistance in cancer treatments. With a PhD in Medical Biochemistry from the University of Turku, Finland, she has a robust background in biotechnology and molecular oncology. Prior to her current role, she excelled at Genentech as a Senior Scientist and group leader, contributing to over 23 target projects and advancing multiple candidates into clinical development. Her research delves deep into tumor heterogeneity and its implications for therapeutic response, showcasing her expertise in both genetic and pharmacologic approaches. Melissa's work has been published in prestigious journals, underscoring her influence in the field. She is passionate about fostering scientific collaboration and innovation in drug discovery. Outside of her professional endeavors, she is committed to mentoring the next generation of scientists in oncology research.
Melissa Junttila
Work Experience
Vice President at
ORIC Pharmaceuticals Inc.
August 2021 - Present
Head of Biology Research at
ORIC Pharmaceuticals Inc.
September 2019 - Present
Senior Scientist at
Genentech Foundation
February 2016 - August 2019
Scientist at
Genentech Foundation
June 2010 - February 2016
Postdoctoral Fellow at
University of California, San Francisco
May 2006 - June 2010
Melissa Junttila
Education
Turun yliopisto - University of Turku, Master's Degree
University of Illinois Urbana-Champaign, Bachelor Of Applied Science (Basc)
Turun yliopisto - University of Turku, Doctor Of Philosophy (Phd)
Frequently Asked Questions about Melissa Junttila
What is Melissa Junttila email address?
Melissa Junttila's primary email address is ****************@oricpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Melissa Junttila work for?
Melissa Junttila is a Vice President at ORIC Pharmaceuticals Inc., a company specializing in Commercial physical research.
Where Melissa Junttila graduated from?
Melissa Junttila holds a degree in Molecular Biology from Turun yliopisto - University of Turku.
How can I directly contact Melissa Junttila?
To contact Melissa Junttila directly, you can use the email address ****************@oricpharma.com. Complete contact information is available upon registration with Muraena.
Is Melissa Junttila an immigrant?
Yes, Melissa Junttila is an immigrant and currently based in United States
Who is Melissa Junttila?
Melissa Junttila is a distinguished Vice President and Head of Biology at ORIC Pharmaceuticals, where she spearheads innovative research aimed at tackling drug resistance in cancer treatments. With a PhD in Medical Biochemistry from the University of Turku, Finland, she has a robust background in biotechnology and molecular oncology. Prior to her current role, she excelled at Genentech as a Senior Scientist and group leader, contributing to over 23 target projects and advancing multiple candidates into clinical development. Her research delves deep into tumor heterogeneity and its implications for therapeutic response, showcasing her expertise in both genetic and pharmacologic approaches. Melissa's work has been published in prestigious journals, underscoring her influence in the field. She is passionate about fostering scientific collaboration and innovation in drug discovery. Outside of her professional endeavors, she is committed to mentoring the next generation of scientists in oncology research.
Melissa`s contact details
****************@oricpharma.com
****************@gene.com
Colleagues
Board Member
Executive Director/Senior Director, Clinical Pharmacology
Executive Director of Translational Medicine
Vice President, Finance
Independent Board Member and Audit Committee Chair
Vice President, Head of People
VP of Finance
VP, Head of CMC